G38S (p.Gly38Ser) variant of SATB2 (DNA-binding protein SATB2)

G38S (p.Gly38Ser) in SATB2 (DNA-binding protein SATB2) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.50 / 1. The record also includes population frequency data and structural context.

G38S (p.Gly38Ser) variant details